
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI
[ Thu, Sep 08th 2022 ]: WOPRAI

[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI
[ Wed, Sep 07th 2022 ]: WOPRAI

[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
[ Tue, Sep 06th 2022 ]: WOPRAI
Amit Hazan Maintained (BVS) at Hold with Decreased Target to $13 on, Sep 7th, 2022


🞛 This publication is a summary or evaluation of another publication
Amit Hazan of Goldman Sachs, Maintained "Bioventus Inc." (BVS) at Hold with Decreased Target from $15 to $13 on, Sep 7th, 2022.
Amit has made no other calls on BVS in the last 4 months.
There is 1 other peer that has a rating on BVS. Out of the 1 peers that are also analyzing BVS, 0 agree with Amit's Rating of Hold.
This is the rating of the analyst that currently disagrees with Amit
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $12 on, Friday, August 12th, 2022